Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Disease

Heart Failure, Systolic

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 10, 2026 · PHASE 1 TRIAL

A Study of LY3971297 in Participants With Heart Failure

ClinicalTrials.gov

Phase 1 safety and tolerability study in heart failure with no posted results; early-stage first-in-patient investigation of a novel mechanism.

PreliminaryEli Lilly and Company LY3971297 Heart Failure, Systolic

Reported

Planned enrollment90

PhasePhase 1

Study duration per participantApproximately 2 months

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support